Samsara Opportunity Fund, L.P. insider trades: Kalaris Therapeutics (KLRS) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Samsara Opportunity Fund, L.P. reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | KLRS | ↑ Buy | 479,847 | $10.42 | $5.0M | By Samsara Opportunity Fund, L.P. | Feb 17, 2026 (61d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KLRS insiders
Open-market trades in the last 12 months
About Samsara Opportunity Fund, L.P.'s insider trades
Samsara Opportunity Fund, L.P. is a 10% owner of Kalaris Therapeutics (KLRS). Since Dec 18, 2025, it has reported 1 open-market purchase worth $5.0M and no sales on SEC Form 4. In the last 12 months: 1 buy ($5.0M).
Its filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KLRS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.